Epidemiology 

The epidemiology of Enterococcus hirae is the study of the distribution and determinants of the infections caused by this bacterium in different populations and settings. Enterococcus hirae is a type of bacteria that belongs to the genus Enterococcus, which is mainly found in animals but can also cause infections in humans, especially in those with weakened immune systems or underlying diseases. Enterococcus hirae can cause urinary tract infections, biliary tract infections, and infective endocarditis. 

According to the web search results, some of the aspects of the epidemiology of Enterococcus hirae are: 

• Enterococcus hirae is primarily a zoonotic disease spread from animals to people via direct contact or food consumption. Some of the animal sources of Enterococcus hirae are poultry, pigs, cattle, and camels. 
• Enterococcus hirae is more likely to cause infections in humans with certain risk factors, such as diabetes, liver cirrhosis, chronic kidney disease, immunosuppression, neurogenic bladder, urinary catheterization, prosthetic valves, and stents. 
• Enterococcus hirae has a high antimicrobial susceptibility and is curable with ampicillin, vancomycin, linezolid, and daptomycin. However, some strains of Enterococcus hirae may resist certain antibiotics, such as erythromycin and tetracycline, so it is essential to perform antibiotic susceptibility testing before initiating treatment. 
• The incidence and prevalence of Enterococcus hirae infections in humans are not well known, as this bacterium is often misidentified or overlooked by conventional diagnostic methods. However, with the advancement of MALDI-TOF MS, a rapid and accurate identification tool, more Enterococcus hirae infections have been reported in recent years. 
• The mortality rate of Enterococcus hirae infections in humans is low compared to other enterococcal species, such as Enterococcus faecalis and Enterococcus faecium. However, complications and relapses may occur if the infection is not treated correctly or promptly. 

Classification and Structure 

• Kingdom: Bacteria 
• Phylum: Firmicutes 
• Class: Bacilli 
• Order: Lactobacillales 
• Family: Enterococcaceae 
• Genus: Enterococcus 
• Species: Enterococcus hirae 

It is a Gram-positive, facultative anaerobic bacterium frequently discovered in human and animal intestines. Enterococcus hirae has a specific cellular structure, which can be described as follows: 

• Cell Shape & Cell Wall: Enterococcus hirae is typically cocci-shaped (spherical), occurring singly, in pairs, or in short chains. Like other Gram-positive bacteria, Enterococcus hirae has a thick peptidoglycan layer in its cell wall, which provides rigidity and support to the cell. The peptidoglycan layer comprises alternating sugars, N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM), cross-linked by short peptides. 
• Cytoplasmic Membrane: Beneath the cell wall, Enterococcus hirae has a cytoplasmic or plasma membrane. This lipid bilayer serves as a barrier between the cell’s interior and the external environment, controlling the passage of molecules in and out of the cell. 
• Cytoplasm: The cytoplasm of Enterococcus hirae contains various components necessary for cellular functions. It includes the nucleoid (containing the bacterial chromosome), ribosomes for protein synthesis, enzymes, metabolic pathways, and other cellular structures. 
• Flagella: Enterococcus hirae is nonmotile and does not possess flagella for locomotion. 
• Pili and Capsules: Enterococcus hirae may produce pili, thin, hair-like appendages that help the bacteria adhere to surfaces or other cells. Some strains of Enterococcus hirae also produce capsules, which are slimy outer layers that aid in evasion of the immune system and attachment to host tissues. 
• Endospores: Enterococcus hirae does not form endospores, which are dormant structures formed by some bacteria to withstand harsh conditions. Instead, it is considered a non-spore-forming bacterium. 

Antigenic Types 

the different variants of the bacteria that have distinct antigenic properties, such as surface proteins or polysaccharides, that can elicit an immune response in the host. Antigenic types are essential for diagnosing, treating, and preventing bacterial infections, as they may affect the susceptibility to antibiotics, virulence, and the immunogenicity of the bacteria. 

Enterococcus hirae has at least four antigenic types: B, C, D, and A—based on the serological reactions of the bacteria with specific antisera. Antigenic type A is the most widespread type, while type B is rare and mainly found in chickens. Type C is associated with endocarditis in humans, while type D is found in pigs and other animals. 

The antigenic types of Enterococcus hirae may also be related to the genetic diversity of the bacteria. A study by Devriese et al. found that Enterococcus hirae strains could be divided into groups based on their DNA-DNA hybridization results: group I and group II. Group I strain were more closely related to Enterococcus durans and Enterococcus villorum, while group II strains were more divergent and included type C and D strains. The authors suggested that group II strains may represent a separate species within the Enterococcus genus. 

Pathogenesis 

Pathogenesis of Enterococcus hirae is the process by which this bacterium causes disease in its host. Enterococcus hirae is a type of bacteria that belongs to the genus Enterococcus, which is mainly found in animals but can also cause infections in humans, especially in those with weakened immune systems or underlying diseases. Enterococcus hirae can cause urinary tract infections, biliary tract infections, and infective endocarditis. 

The pathogenesis of Enterococcus hirae involves several factors, such as : 

• Adherence: Enterococcus hirae can attach to the host cells or tissues by using surface proteins, such as enterococcal surface protein (Esp), aggregation substance (AS), and collagen-binding protein (Ace). These proteins can mediate the binding of Enterococcus hirae to the urinary tract, the biliary tract, and the heart valves, respectively. 
• Invasion: Enterococcus hirae can invade the host cells by using secreted enzymes, such as gelatinase (GelE) and serine protease (SprE). These enzymes can degrade the extracellular matrix and the host cell membrane, allowing Enterococcus hirae to enter the cytoplasm or the intracellular compartments. 
• Biofilm formation: Enterococcus hirae can form biofilms on the host surfaces or devices, such as catheters, prosthetic valves, and stents. Biofilms are bacteria communities encapsulated in an extracellular polymeric substance (EPS) matrix. Biofilms can protect Enterococcus hirae from the host immune system and the antibiotics and facilitate the infection’s persistence and dissemination. 
• Toxin production: Enterococcus hirae can produce toxins that can damage the host cells or tissues, such as cytolysin (Cyl) and bacteriocin (Ent). Cytolysin is a hemolysin that can lyse the red blood cells and other cells, causing hemolysis, inflammation, and tissue necrosis. Bacteriocin is an antimicrobial peptide that can kill other bacteria, including competing enterococci or beneficial microbiota. 

Host Defenses 

The host defenses of Enterococcus hirae may vary depending on the site and severity of the infection and the host’s immune status. However, some of the general host defenses that may be involved are: 

• The skin and mucous: Enterococcus hirae is physically barred from entering the body by the skin & mucous membranes. Additionally, they secrete antimicrobial compounds like lysozyme and lactoferrin that can stop Enterococcus hirae from growing. 
• The innate immune: Without prior exposure, the innate immune system’s cells and molecules can recognize and get rid of Enterococcus hirae. These include natural killer cells, neutrophils, macrophages, complement systems, & cytokines. They can cause inflammation, opsonize Enterococcus hirae, kill it, or phagocytose it. They can also draw additional immune cells to the infection site. 
• The adaptive immune system consists of cells and molecules that can generate a specific and long-lasting response to Enterococcus hirae after exposure. These include B cells, T cells, antibodies, and memory cells. They can produce antibodies that neutralize or opsonize Enterococcus hirae and activate the complement system and phagocytes. They can also produce cytotoxic T cells that can directly kill infected cells and helper T cells that regulate the immune response. 

• The urinary tract has defense mechanisms that can prevent or limit the infection by Enterococcus hirae. These include urine flow, acidity, osmolality, urea concentration, inhibitors, and urothelial cells. They can flush out, acidify, dehydrate, or inhibit the growth of Enterococcus hirae and prevent its adherence to the urothelial cells. 
• The biliary tract has defense mechanisms that can prevent or limit the infection by Enterococcus hirae. These include bile flow, salts, bile acids, immunoglobulin A (IgA), and biliary epithelial cells. They can flush out, emulsify, or kill Enterococcus hirae, preventing adherence to the biliary epithelial cells. 

Clinical manifestations 

the symptoms of Enterococcus hirae infection are like those of other enterococcal infections, such as urinary tract infections, biliary tract infections, and infective endocarditis. These symptoms may include: 

• A vital and ongoing need to urinate or pee. 
• A burning feeling when urinating 
• Frequently passing only small amounts of urine 
• Cloudy, red, pink, or cola-colored urine 
• Lower abdominal pain 
• Fever and chills 
• Nausea and vomiting 
• Light-headedness or confusion 
• Headache 
• Pain or pressure in the lower abdomen 
• Wound swelling, redness, and drainage 

Diagnosis 

Methods to diagnose Enterococcus hirae infection: 

• Conventional bacteriological methods: Culturing the clinical sample on specific media and performing biochemical tests for species identification. Simple and inexpensive but time-consuming and may not differentiate closely related species. 
• Polymerase chain reaction (PCR): Amplifying and detecting Enterococcus hirae DNA sequences using primers and probes. Rapid and accurate results but requires specialized equipment and trained personnel. 
• Using MALDI-TOF MS, a matrix-assisted laser desorption ionisation time of flight mass spectrometry technique: Analyzing the protein profile of Enterococcus hirae using a mass spectrometer. It provides quick identification and differentiation of species but requires expensive equipment and software. 
• Loop-mediated isothermal amplification (LAMP): Amplifying and detecting Enterococcus hirae DNA sequences under isothermal conditions. Rapid, sensitive, and can be visualized by color change or fluorescence.  

Control 

Enterococcus hirae is a type of bacteria that can cause infections in humans, especially those with weakened immune systems or underlying diseases. Some of the ways to prevent Enterococcus hirae infection are: 

• Wash your hands with warm water and soap throughout the day. Always wash after you use the bathroom and before you eat or prepare food. 
• Don’t share personal items with anyone, especially people you know are sick. It includes forks and spoons. 
• Wipe down shared items like TV remotes, phones, and computers with disinfectant. 
• To prevent getting sick and passing on bacteria that can lead to infections, keep your hands clean. 
• Frequently clean areas of the home, such as bathrooms, that may become contaminated with Enterococcus hirae. 
• Wear gloves if hands encounter body fluids containing Enterococcus hirae, such as stool or bandages from infected wounds. 
• Prevent immunosuppressive diseases and conditions, such as diabetes, liver cirrhosis, and chronic kidney disease, by following your doctor’s advice and taking your medications as prescribed. 
• Ensure proper cleaning and disinfection of the facilities if you work in a healthcare setting or visit a hospital. 

• Water sanitation helps to reduce the incidence of Enterococcus hirae infection. 

References 

• Enterococcus hirae bacteremia associated with acute pyelonephritis in a patient with alcoholic cirrhosis: a case report and literature review | BMC Infectious Diseases | Full Text (biomedcentral.com) 
• Enterococcus hirae Bacteremia in an Infant: Case Report and Review of the Literature | Journal of the Pediatric Infectious Diseases Society | Oxford Academic (oup.com)